结合治疗偏头痛预防:最先进的技术状态
Lanfranco Pellesi1, David Garcia-Azorin2,3, Eloisa Rubio-Beltrán4
1Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Campusvej 55, Odense, 5230, Denmark. lpellesi@health.sdu.dk.
The journal of headache and pain
|December 5, 2024
概括
对于偏头痛预防的组合疗法,包括CGRP治疗和甲胺毒素A,显示出有前途. 需要进一步的研究,以建立安全和有效的协议,这些先进的偏头痛治疗.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 偏头痛预防需要不同的方法,因为复杂的潜在机制.
- 组合治疗为增强偏头痛管理提供了一个有希望的策略.
- 目前的指导方针缺乏证据证明许多组合疗法.
研究的目的:
- 审查结合各种偏头痛预防治疗的潜力.
- 探索涉及口服药物,甲基毒素A和CGRP向疗法的组合.
- 确定对混合偏头痛治疗的挑战和未来的研究需求.
主要方法:
- 对偏头痛预防的组合疗法的文献综述.
- 分析了结合口服常规预防药物,甲本毒素A,向CGRP的单克隆抗体 (mAbs) 和小分子CGRP受体对手 (gepants) 的策略.
主要成果:
- 双重CGRP抑制 (mAbs和gepants) 可能会提高疗效.
- 有机毒素A与CGRP治疗相结合,可以提供协同作用的疼痛缓解.
- 口服非CGRP治疗为组合疗法提供了可访问的选择.
结论:
- 组合疗法对偏头痛预防有很大的潜力.
- 支持广泛纳入临床指南的证据有限.
- 高昂的成本和缺乏大规模试验需要进一步的研究,以建立安全有效的方案,特别是对于耐治疗病例.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:23Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:27Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174